Lmcg Investments, LLC Mirati Therapeutics, Inc. Transaction History

Lmcg Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$27.8 - $45.35 $3,614 - $5,895	130 Added 2.24%	5,933 $258,000
Q1 2023 May 04, 2023	BUY	$36.54 - $54.26 $4,932 - $7,325	135 Added 2.38%	5,803 $215,000
Q4 2022 Feb 06, 2023	BUY	$41.27 - $98.62 $495 - $1,183	12 Added 0.21%	5,668 $256,000
Q3 2022 Nov 07, 2022	BUY	$59.5 - $86.7 $2,082 - $3,034	35 Added 0.62%	5,656 $395,000
Q1 2022 May 10, 2022	BUY	$75.82 - $150.97 $426,184 - $848,602	5,621 New	5,621 $462,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Lmcg Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Lmcg Investments, LLC with notifications on news.